United States · FDA National Drug Code directory

Badiaga

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63545-351_c50e45f6-6d8c-7582-e053-2a95a90a951d
Product NDC
63545-351
Form
PELLET
Composition / generic term
Badiaga
Labeler
Hahnemann Laboratories, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20210618
Source listing expiry
20261231

Source-listed ingredients

  • SPONGILLA LACUSTRIS — 1 [hp_M]/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 200 PELLET in 1 VIAL, GLASS (63545-351-01) · 63545-351-01
  • 500 PELLET in 1 VIAL, GLASS (63545-351-02) · 63545-351-02
  • 3000 PELLET in 1 BOTTLE, GLASS (63545-351-03) · 63545-351-03
  • 10000 PELLET in 1 BOTTLE, GLASS (63545-351-04) · 63545-351-04

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →